Evoke Wealth’s NeueHealth NEUE Stock Holding History

Evoke Wealth’s Portfolio NEUE Stock Details NEUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,524	Closed	-$1.53M	–	1285
2022 Q2	$1.53M	Buy	+10,524	New	+$1.53M	0.06%	124

Other funds holding NEUE

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return

Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Evoke Wealth's NEUE Position: Q3 2022 in Review

Evoke Wealth sold out of NeueHealth (NEUE) in Q3 2022, closing a stake of 10,524 shares — an estimated $1.53M sold.

Evoke Wealth first reported a position in NEUE in Q2 2022 and held it in 1 quarter. The position peaked at $1.53M in Q2 2022. 128 funds tracked by Wall St. Rank hold NEUE as of Q3 2022.

Evoke Wealth reported no remaining NeueHealth position as of Q3 2022 after selling out during the quarter.
Evoke Wealth sold 10,524 NeueHealth shares in Q3 2022, an estimated $1.53M.
Evoke Wealth first reported a position in NeueHealth in Q2 2022 and held it in 1 quarter.
Evoke Wealth's NeueHealth position peaked at $1.53M in Q2 2022.
128 funds tracked by Wall St. Rank held NeueHealth as of Q3 2022.

Based on Evoke Wealth's 13F filing for Q3 2022, filed 7 Nov 2022.